A cellular recycling process called autophagy helps determine whether pancreatic cancer cells grow quickly or hunker into survival mode…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
Telix Pharmaceuticals has submitted an application to European regulators seeking approval for TLX101-Px, the company’s experimental imaging agent designed…
Nuvation Bio expanded a trial testing its experimental therapy, safusidenib, in people with certain forms of glioma that…
GYNECOLOGICAL CANCER
Ovarian cancer drug lira-cel extends survival ‘far longer’ than expected
In an early clinical trial in the U.S., most women with hard-to-treat ovarian cancer given a low dose of…
Anito-cel (anitocabtagene autoleucel), a cell therapy in clinical development as a potential treatment for myeloma, may be less likely…
PANCREATIC CANCER
FDA gives green light to first human trial testing cancer drug GTB-5550
A first-in-human clinical trial will launch in the coming months to test GTB-5550, an immune therapy from GT Biopharma that’s…
A team of scientists at the University of Cincinnati Cancer Center is embarking on a series of tests to evaluate…
A treatment regimen combining Darzalex Faspro (daratumumab and hyaluronidase-fihj) with three other medications is now approved in the U.S.
The U.S. Food and Drug Administration (FDA) has granted fast-track designation to QTX-2101, an oral formulation of an approved chemotherapy…
PANCREATIC CANCER
Patients sought for first-in-human trial of pancreatic cancer treatment
A first-in-human clinical trial testing RMC-5127, an experimental treatment for people with pancreatic cancer and other cancers marked by…